Faculty Opinions recommendation of Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO).

2017 ◽  
Author(s):  
Ravi Kalhan ◽  
Sharon R Rosenberg
Keyword(s):  
Inhaled Corticosteroids ◽  
Real Life ◽  
Low Risk ◽  
Life Study ◽  
Copd Patients ◽  
Real Life Study

scholarly journals Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids

PLoS ONE ◽  
2017 ◽  
Vol 12 (6) ◽  
pp. e0178112 ◽  
Author(s):  
Samatha Sonnappa ◽  
Richard Martin ◽  
Elliot Israel ◽  
Dirkje Postma ◽  
Wim van Aalderen ◽  
...  
Keyword(s):  
Lung Disease ◽  
Fine Particle ◽  
Obstructive Lung Disease ◽  
Inhaled Corticosteroids ◽  
Real Life ◽  
Life Study ◽  
Real Life Study

scholarly journals Demographic, Clinical and Management Characteristics of Newly Diagnosed COPD Patients in Turkey: A Real-Life Study

2020 ◽  
Vol Volume 15 ◽  
pp. 261-267
Author(s):  
Mecit Suerdem ◽  
Hakan Gunen ◽  
Levent Akyildiz ◽  
Aykut Cilli ◽  
Tevfik Ozlu ◽  
...  
Keyword(s):  
Real Life ◽  
Newly Diagnosed ◽  
Life Study ◽  
Copd Patients ◽  
Real Life Study

Baseline data of the DEVIDE-study: DEnosumab vs Intravenous Ibandronate: a 2-year retrospective head to head real life study

2014 ◽  
Author(s):  
Karin Amrein ◽  
Christian Muschitz ◽  
Doris Wagner ◽  
Thomas R Pieber ◽  
Heinrich Resch ◽  
...  
Keyword(s):  
Real Life ◽  
Baseline Data ◽  
Life Study ◽  
Real Life Study

Pegvisomant: daily versus non daily administration a single centre real life study

2019 ◽  
Author(s):  
Francesca Dassie ◽  
Marco Rosson ◽  
Matteo Parolin ◽  
Lucia Russo ◽  
Sara Mazzocut ◽  
...  
Keyword(s):  
Real Life ◽  
Daily Administration ◽  
Single Centre ◽  
Life Study ◽  
Real Life Study
Sign in / Sign up

Export Citation Format

Share Document